IBDEI0SK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12855,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,OD
 ;;^UTILITY(U,$J,358.3,12855,1,4,0)
 ;;=4^H35.421
 ;;^UTILITY(U,$J,358.3,12855,2)
 ;;=^5005675
 ;;^UTILITY(U,$J,358.3,12856,0)
 ;;=H35.422^^51^622^20
 ;;^UTILITY(U,$J,358.3,12856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12856,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,OS
 ;;^UTILITY(U,$J,358.3,12856,1,4,0)
 ;;=4^H35.422
 ;;^UTILITY(U,$J,358.3,12856,2)
 ;;=^5005676
 ;;^UTILITY(U,$J,358.3,12857,0)
 ;;=H35.423^^51^622^21
 ;;^UTILITY(U,$J,358.3,12857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12857,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,Bilateral
 ;;^UTILITY(U,$J,358.3,12857,1,4,0)
 ;;=4^H35.423
 ;;^UTILITY(U,$J,358.3,12857,2)
 ;;=^5005677
 ;;^UTILITY(U,$J,358.3,12858,0)
 ;;=H35.451^^51^622^23
 ;;^UTILITY(U,$J,358.3,12858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12858,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,OD
 ;;^UTILITY(U,$J,358.3,12858,1,4,0)
 ;;=4^H35.451
 ;;^UTILITY(U,$J,358.3,12858,2)
 ;;=^5005687
 ;;^UTILITY(U,$J,358.3,12859,0)
 ;;=H35.452^^51^622^24
 ;;^UTILITY(U,$J,358.3,12859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12859,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,OS
 ;;^UTILITY(U,$J,358.3,12859,1,4,0)
 ;;=4^H35.452
 ;;^UTILITY(U,$J,358.3,12859,2)
 ;;=^5005688
 ;;^UTILITY(U,$J,358.3,12860,0)
 ;;=H35.453^^51^622^25
 ;;^UTILITY(U,$J,358.3,12860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12860,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,Bilateral
 ;;^UTILITY(U,$J,358.3,12860,1,4,0)
 ;;=4^H35.453
 ;;^UTILITY(U,$J,358.3,12860,2)
 ;;=^5005689
 ;;^UTILITY(U,$J,358.3,12861,0)
 ;;=H35.381^^51^622^16
 ;;^UTILITY(U,$J,358.3,12861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12861,1,3,0)
 ;;=3^Toxic Maculopathy,OD
 ;;^UTILITY(U,$J,358.3,12861,1,4,0)
 ;;=4^H35.381
 ;;^UTILITY(U,$J,358.3,12861,2)
 ;;=^5005666
 ;;^UTILITY(U,$J,358.3,12862,0)
 ;;=H35.382^^51^622^17
 ;;^UTILITY(U,$J,358.3,12862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12862,1,3,0)
 ;;=3^Toxic Maculopathy,OS
 ;;^UTILITY(U,$J,358.3,12862,1,4,0)
 ;;=4^H35.382
 ;;^UTILITY(U,$J,358.3,12862,2)
 ;;=^5005667
 ;;^UTILITY(U,$J,358.3,12863,0)
 ;;=H35.383^^51^622^18
 ;;^UTILITY(U,$J,358.3,12863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12863,1,3,0)
 ;;=3^Toxic Maculopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,12863,1,4,0)
 ;;=4^H35.383
 ;;^UTILITY(U,$J,358.3,12863,2)
 ;;=^5005668
 ;;^UTILITY(U,$J,358.3,12864,0)
 ;;=H35.343^^51^622^12
 ;;^UTILITY(U,$J,358.3,12864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12864,1,3,0)
 ;;=3^Macular Cyst,Hole,or Pseudohole,Bilateral
 ;;^UTILITY(U,$J,358.3,12864,1,4,0)
 ;;=4^H35.343
 ;;^UTILITY(U,$J,358.3,12864,2)
 ;;=^5005652
 ;;^UTILITY(U,$J,358.3,12865,0)
 ;;=H35.031^^51^623^1
 ;;^UTILITY(U,$J,358.3,12865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12865,1,3,0)
 ;;=3^HTN Retinopathy,OD
 ;;^UTILITY(U,$J,358.3,12865,1,4,0)
 ;;=4^H35.031
 ;;^UTILITY(U,$J,358.3,12865,2)
 ;;=^5005590
 ;;^UTILITY(U,$J,358.3,12866,0)
 ;;=H35.032^^51^623^2
 ;;^UTILITY(U,$J,358.3,12866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12866,1,3,0)
 ;;=3^HTN Retinopathy,OS
 ;;^UTILITY(U,$J,358.3,12866,1,4,0)
 ;;=4^H35.032
 ;;^UTILITY(U,$J,358.3,12866,2)
 ;;=^5005591
 ;;^UTILITY(U,$J,358.3,12867,0)
 ;;=H35.033^^51^623^3
 ;;^UTILITY(U,$J,358.3,12867,1,0)
 ;;=^358.31IA^4^2
